Tauns Laboratories (TSE:197A) EPS (Basic): 円19.90 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
15 GF Score
Price 円468.00
! 5 Warning Signs
View Full Analysis

What is Tauns Laboratories EPS (Basic)?

Tauns Laboratories TSE:197A 15 EPS (Basic) is 円19.90 as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 15/100. The stock has 5 warning signs investors should review.

Tauns Laboratories's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was 円16.40. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was 円19.90.

Tauns Laboratories's EPS (Diluted) for the three months ended in Dec. 2025 was 円15.85. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円19.88.

Tauns Laboratories's EPS without NRI for the three months ended in Dec. 2025 was 円17.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 19.22.

During the past 3 years, the average EPS without NRI Growth Rate was -5.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Tauns Laboratories's highest 3-Year average EPS without NRI Growth Rate was -5.40% per year. The lowest was -5.40% per year. And the median was -5.40% per year.

Tauns Laboratories  (TSE:197A) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Tauns Laboratories EPS (Basic) Related Terms

Tauns Laboratories EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories EPS (Basic) Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
EPS (Basic)
44.81 30.35 57.74 62.07

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.14 -3.46 3.47 16.40 3.49
TSE:197A
15GF Score
Tauns Laboratories Inc TSE:197A
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Tauns Laboratories's Basic EPS for the fiscal year that ended in Jun. 2025 is calculated as

Basic EPS (A: Jun. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(6315.407-0)/101.740
=62.07

Tauns Laboratories's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1702.669-0)/103.709
=16.42

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円19.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of 円19.90 mean?
Tauns Laboratories (TSE:197A) has a EPS (Basic) of 円19.90 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' EPS (Basic) too high?
Tauns Laboratories' current EPS (Basic) is 円19.90. Overall, Tauns Laboratories has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' EPS (Basic) compare to ISRG and BDX?
Tauns Laboratories' EPS (Basic) of 円19.90 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current EPS (Basic) is 円19.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current EPS (Basic) of 円19.90. The current EPS (Basic) is 円19.90. Tauns Laboratories' overall GF Score™ is 15/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current EPS (Basic) is 円19.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
15GF Score

Get the complete analysis for TSE:197A

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円468.00
Price